BDULF

Bangkok Dusit Medical Services Public Company Limited BDULF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BDULF RCDTF SFOSF MTHRY MTHRF GIFLF CSPCY BIOVF SSMXF WILLF
6M -1.61 % 0.00 % 41.33 % -3.49 % 0.81 % 1.83 % 6.71 % 30.27 % -37.80 % -18.22 %
YTD -28.24 % 17.82 % 53.89 % 53.83 % 65.19 % 22.09 % 90.78 % 24.56 % -51.71 % -8.39 %
1Y -28.24 % 25.24 % 55.62 % 55.63 % 41.42 % 22.09 % 82.11 % 27.44 % -51.71 % -9.03 %
3Y -29.89 % 61.98 % -12.34 % -50.63 % -50.14 % 9.28 % 1.78 % 66.67 % -84.39 % 23.82 %
5Y -9.06 % 19.53 % -43.58 % -85.64 % -84.82 % -59.92 % 13.00 % 82.36 % -89.16 % -6.60 %
10Y 1.67 % 154.63 % -4.15 % -68.59 % -47.48 % -48.75 % 48.38 % 82.36 % -84.85 % 86.16 %
From the beginning 388.00 % 709.90 % -18.29 % -68.59 % -48.48 % -99.94 % 48.38 % 82.36 % -99.94 % 301.13 %

Dividend

Bangkok Dusit Medical Services Public Company Limited

Recordati Industria Chimica e Farmaceutica S.p.A.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

M3, Inc.

M3, Inc.

Grifols, S.A.

CSPC Pharmaceutical Group Limited

Sysmex Corporation